openPR Logo
Press release

Venous Stents Market is Anticipated to Register a CAGR of 9.95% Between 2017 - 2025

03-22-2018 12:24 PM CET | Health & Medicine

Press release from: Transparency Market Research

Venous Stents Market is Anticipated to Register a CAGR of 9.95%

This report on the Global Venous Stents market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel venous stents, increase in prevalence of chronic venous occlusion & other symptomatic venous disorders and their improved diagnosis are boosting the growth of the Global Venous Stents market. Improved access to the deep long veins located in the iliac and femoral portion of the body, and availability of well-qualified interventional cardiologists in the developed countries are some of the factors expected to drive the growth of Global Venous Stents market during the forecast period.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34877

The venous stents report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on technology, application, disease indication, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises exhaustive mapping of all the products & companies operating in the global venous stents market, to help understand the competitive landscape in the market. An overview of critical venous diseases such as May-Thurner Syndrome and Post Thrombotic Syndrome in terms of their prevalence, diagnosis, symptoms, and treatment options are provided. A brief snapshot of ongoing clinical trials in the U.S. is also provided for better understanding of venous stents scenario in the U.S. This report also provides market attractiveness and its analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Global Venous Stents market.

Based on the technology, the Venous Stents market has been segmented into Iliac vein Stent Technology, Wallstent Technology, and Others. Iliac Vein Stent Technology is considered to be a leading segment of Venous Stents market, owing to the improved access to the deep veins of iliac area. It is expected to continue to dominate the market in terms of revenue by 2025, which is attributed to the increasing investments by key players for the development of venous stents. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Different types of applications in the Venous Stents market are Leg, Chest, Abdomen, and Arm. Legs accounted for highest market revenue in 2016, and is expected to remain leading in terms of revenue during the forecast period. The dominance is attributed to the shift of patients’ preference towards minimally invasive interventional procedures for the occlusion in femoral & popliteal veins.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=34877

Based on disease indication, the global Venous Stents market is segmented into 5 major segments, which are Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae, and Others. Other disease segment comprised of venous anastomosis, restenosis, and venous occlusions among others. The others segment is anticipated to lead the market during the forecast period, owing to the government participation in the control of venous disorders, and research grants by public & private players to promote the R&D of innovative venous stents.

Geographically, the global Venous Stents has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa).

The report also profiles major players in the Global Venous Stents based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Boston Scientific Corporation, C. R. Bard, Inc., Jotec GmBH, Veniti, Inc., Gore Medical, Cook Medical, and Optimed Medizinische Instrumente GmBH.

Report Overview @ https://www.transparencymarketresearch.com/venous-stents-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Stents Market is Anticipated to Register a CAGR of 9.95% Between 2017 - 2025 here

News-ID: 988782 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Stent

Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Global Coronary Stent Grafts Market to Observe Strong Development during the For …
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still